Fake Avastin contained several chemicals, no drug

(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

The Swiss drugmaker says an analysis of the contents of the vials picked up traces of 10 substances, ranging from starch and salt to chemicals like acetone, a solvent used in paint thinner.

Roche said it is unclear whether the substances would cause harmful effects in patients.

The is investigating the source of counterfeit imported and distributed by a U.S. wholesaler to doctors here. Authorities in Europe have traced the counterfeit product back through distributors in Britain, Denmark and Switzerland. The original country of origin is still unclear.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Counterfeit toothpaste is discovered

Jun 14, 2007

The U.S. Food and Drug Administration said a counterfeit toothpaste falsely packaged as "Colgate" has been found in four states.

Counterfeit drugs becoming big business worldwide

Feb 16, 2012

(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly ...

Recommended for you

Journal raises concern about blood-thinning drug

11 hours ago

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

Supermaterial gives rejected drugs a new chance

Jul 22, 2014

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

User comments